 Connection
Elaine Morrato to Schizophrenia
This is a "connection" page, showing publications Elaine Morrato has written about Schizophrenia.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.818 |
|
|
|
-
Morrato EH. Interpreting evidence on long-acting injectable antipsychotics. Lancet Psychiatry. 2021 05; 8(5):349-351.
Score: 0.527
-
Morrato EH, Campagna EJ, Brewer SE, Dickinson LM, Thomas DS, Miller BF, Dearing J, Druss BG, Lindrooth RC. Metabolic Testing for Adults in a State Medicaid Program Receiving Antipsychotics: Remaining Barriers to Achieving Population Health Prevention Goals. JAMA Psychiatry. 2016 Jul 01; 73(7):721-30.
Score: 0.378
-
Morrato EH, Parks J, Campagna EJ, Muser E, Thomas DS, Fang H, Doshi D. Comparative effectiveness of injectable paliperidone palmitate versus oral atypical antipsychotics: early postmarketing evidence. J Comp Eff Res. 2015 Mar; 4(2):89-99.
Score: 0.335
-
Campagna EJ, Muser E, Parks J, Morrato EH. Methodological considerations in estimating adherence and persistence for a long-acting injectable medication. J Manag Care Spec Pharm. 2014 Jul; 20(7):756-66.
Score: 0.329
-
Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R, Valuck RJ. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003. Clin Ther. 2007 Jan; 29(1):183-95.
Score: 0.196
-
Morrato EH, Newcomer JW, Allen RR, Valuck RJ. Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data. J Clin Psychiatry. 2008 Feb; 69(2):316-22.
Score: 0.053
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|